Adam Koppel, Director at Dicerna Pharmaceuticals Inc (DRNA), sold 1,500,000 shares at $24.68 ($37.0M) on 2019-12-04, disclosed to the SEC on 2019-12-06.
Open-market sale of $37.0M DRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SWTX | SELL | 2021-03-11 | $103.7M | — | Filing → |
| DRNA | SELL | 2020-12-14 | $23.4M | — | Filing → |
| CERE | BUY | 2020-11-12 | $6.8M | — | Filing → |